Suppr超能文献

一种哺乳动物糖基转移酶(人β1,4-半乳糖基转移酶)在酵母中的高尔基体定位及体内活性

Golgi localization and in vivo activity of a mammalian glycosyltransferase (human beta1,4-galactosyltransferase) in yeast.

作者信息

Schwientek T, Narimatsu H, Ernst J F

机构信息

Institut für Mikrobiologie, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany.

出版信息

J Biol Chem. 1996 Feb 16;271(7):3398-405. doi: 10.1074/jbc.271.7.3398.

Abstract

Gene fusions encoding the membrane anchor region of yeast alpha1, 2-mannosyltransferase (Mnt1p) fused to human beta1, 4-galactosyltransferase (Gal-Tf) were constructed and expressed in the yeast Saccharomyces cerevisiae. Fusion proteins containing 82 or only 36 N-terminal residues of Mnt1p were produced and quantitatively N-glycosylated; glycosyl chains were shown to contain alpha1,6-, but not alpha1,3-mannose determinants, a structure typical for an early Golgi compartment. A final Golgi localization of both fusions was confirmed by sucrose gradient fractionations, in which Gal-Tf activity cofractionated with Golgi Mnt1p activity, as well as by immunocytological localization experiments using a monoclonal anti-Gal-Tf antibody. In an in vitro Gal-Tf enzymatic assay the Mnt1/Gal-Tf fusion and soluble human Gal-Tf had comparable Km values for UDP-Gal (about 45 microM). To demonstrate in vivo activity of the Mnt1/Gal-Tf fusion the encoding plasmids were transformed in an alg1 mutant, which at the non-permissive temperature transfers short (GlcNAc)2 glycosyl chains to proteins. Using specific lectins the addition of galactose to several yeast proteins in transformants could be detected. These results demonstrate that Gal-Tf, a mammalian glycosyltransferase, is functional in the molecular environment of the yeast Golgi, indicating conservation between yeast and human cells. The in vivo function of human Gal-Tf indicates that the yeast Golgi is accessible for UDP-Gal and suggests strategies for the construction of yeast strains, in which desired glycoforms of heterologous proteins are produced.

摘要

构建了编码与人类β1,4-半乳糖基转移酶(Gal-Tf)融合的酵母α1,2-甘露糖基转移酶(Mnt1p)膜锚定区的基因融合体,并在酿酒酵母中表达。产生了包含82个或仅36个Mnt1p N端残基的融合蛋白,并进行了定量N-糖基化;糖基链显示含有α1,6-甘露糖决定簇,但不含α1,3-甘露糖决定簇,这是早期高尔基体区室的典型结构。通过蔗糖梯度分级分离证实了两种融合体的高尔基体终末定位,其中Gal-Tf活性与高尔基体Mnt1p活性共分级,以及通过使用单克隆抗Gal-Tf抗体的免疫细胞定位实验。在体外Gal-Tf酶活性测定中,Mnt1/Gal-Tf融合体和可溶性人类Gal-Tf对UDP-Gal的Km值相当(约45μM)。为了证明Mnt1/Gal-Tf融合体的体内活性,将编码质粒转化到alg1突变体中,该突变体在非允许温度下将短的(GlcNAc)2糖基链转移到蛋白质上。使用特异性凝集素可以检测到转化体中几种酵母蛋白上半乳糖的添加。这些结果表明,哺乳动物糖基转移酶Gal-Tf在酵母高尔基体的分子环境中具有功能,表明酵母和人类细胞之间存在保守性。人类Gal-Tf的体内功能表明酵母高尔基体可利用UDP-Gal,并提出了构建产生所需糖型异源蛋白的酵母菌株的策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验